Trust Size
$4M
Peak Price
$25600.00
Current Price
$0.04
Return
-99.6%
What Happened
Cero Therapeutics Holdings, Inc. filed its S-1 registration in 2021 and completed its business combination in 2024. The company remains actively traded with 419 SEC filings on record.
Cero Therapeutics Holdings, Inc. entered the SPAC market in 2021 with its initial S-1 filing with the SEC, joining the wave of blank check companies seeking acquisition targets.
The company filed a definitive proxy statement (DEFM14A) ahead of its merger vote, completing its de-SPAC transaction in 2024.
SEC records show 419 total filings, including annual (10-K) and quarterly (10-Q) financial reports.
The company was incorporated in Delaware, the preferred jurisdiction for the vast majority of SPACs due to its business-friendly legal framework.
Timeline
2021-09-28
S-1 Registration Filed
2024-01-22
Merger Proxy Filed (DEFM14A)
SEC Filing Details
CIK Number
1870404
Total SEC Filings
419
State of Incorporation
DE
Last Filing Date
2026-03-12
Business Location
Philadelphia, PA
Trust/Asset Size
$4M
Data sourced from SEC EDGAR Company Facts API and EFTS search index.
ð SEC Filings
View all EDGAR filings for Cero Therapeutics Holdings